{"id":"https://openalex.org/W7204242438","doi":"https://doi.org/10.1097/01.jaa.0000000000000408","title":"Precision oncology in breast cancer","display_name":"Precision oncology in breast cancer","publication_year":2026,"publication_date":"2026-08-25","ids":{"openalex":"https://openalex.org/W7204242438","doi":"https://doi.org/10.1097/01.jaa.0000000000000408","pmid":"https://pubmed.ncbi.nlm.nih.gov/42647673"},"language":"en","primary_location":{"id":"doi:10.1097/01.jaa.0000000000000408","doi":"https://doi.org/10.1097/01.jaa.0000000000000408","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.jaa.0000000000000408","pdf_url":null,"source":{"id":"https://openalex.org/S4393917531","display_name":"JAAPA","issn_l":"0893-7400","issn":["0893-7400","1547-1896"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["doyens","medline","norway-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAAPA","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5148200840","display_name":"Whitney Tobin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088931","display_name":"Virginia Oncology Associates","ror":"https://ror.org/009yyqs39","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210088931"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Whitney Tobin","raw_affiliation_strings":["Whitney Tobin is a PA specializing in hematology and oncology at Virginia Oncology Associates in Norfolk, VA. The author has disclosed no potential conflicts of interest, financial or otherwise"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Whitney Tobin is a PA specializing in hematology and oncology at Virginia Oncology Associates in Norfolk, VA. The author has disclosed no potential conflicts of interest, financial or otherwise","institution_ids":["https://openalex.org/I4210088931"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5148200840"],"corresponding_institution_ids":["https://openalex.org/I4210088931"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.65778757,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"39","issue":"9","first_page":"35","last_page":"43"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.6894999742507935,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.6894999742507935,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.295199990272522,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/precision-oncology","display_name":"precision oncology","score":0.9779999852180481},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8880000114440918},{"id":"https://openalex.org/keywords/molecular-subtypes","display_name":"molecular subtypes","score":0.8009999990463257},{"id":"https://openalex.org/keywords/hormone-receptor-positive-breast-cancer","display_name":"hormone receptor-positive breast cancer","score":0.8889999985694885},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9959999918937683},{"id":"https://openalex.org/keywords/her2-low-breast-cancer","display_name":"HER2-low breast cancer","score":0.9739999771118164},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":1.0},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.9950000047683716},{"id":"https://openalex.org/keywords/selective-estrogen-receptor-degrader","display_name":"selective estrogen receptor degrader","score":0.9869999885559082},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9850000143051147},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.9039999842643738},{"id":"https://openalex.org/keywords/genomic-profiling","display_name":"genomic profiling","score":0.7979999780654907},{"id":"https://openalex.org/keywords/circulating-tumor-dna","display_name":"circulating tumor DNA","score":0.9919999837875366},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.6000000238418579},{"id":"https://openalex.org/keywords/clinical-trial-coordination","display_name":"clinical trial coordination","score":0.6539999842643738}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7538999915122986},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7494000196456909},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5756999850273132},{"id":"https://openalex.org/C163763905","wikidata":"https://www.wikidata.org/wiki/Q17075943","display_name":"Precision medicine","level":2,"score":0.5515000224113464},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5181999802589417},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47699999809265137},{"id":"https://openalex.org/C3020497934","wikidata":"https://www.wikidata.org/wiki/Q17075943","display_name":"Precision oncology","level":3,"score":0.459199994802475},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.45329999923706055},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4426000118255615},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.43689998984336853},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.4171000123023987},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.38420000672340393},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.38190001249313354},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.37630000710487366},{"id":"https://openalex.org/C32220436","wikidata":"https://www.wikidata.org/wiki/Q2072214","display_name":"Personalized medicine","level":2,"score":0.37049999833106995},{"id":"https://openalex.org/C2776598537","wikidata":"https://www.wikidata.org/wiki/Q1812651","display_name":"Clinical Oncology","level":3,"score":0.36730000376701355},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.3305000066757202},{"id":"https://openalex.org/C3020000666","wikidata":"https://www.wikidata.org/wiki/Q17112037","display_name":"Bench to bedside","level":2,"score":0.31610000133514404},{"id":"https://openalex.org/C2908728163","wikidata":"https://www.wikidata.org/wiki/Q415271","display_name":"Human Epidermal Growth Factor Receptor 2","level":4,"score":0.305400013923645},{"id":"https://openalex.org/C128544194","wikidata":"https://www.wikidata.org/wiki/Q474859","display_name":"Translational research","level":2,"score":0.3010999858379364},{"id":"https://openalex.org/C3018877446","wikidata":"https://www.wikidata.org/wiki/Q1421432","display_name":"Disease monitoring","level":3,"score":0.2808000147342682},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.27799999713897705},{"id":"https://openalex.org/C3019816032","wikidata":"https://www.wikidata.org/wiki/Q2575340","display_name":"Cancer treatment","level":3,"score":0.27790001034736633},{"id":"https://openalex.org/C2777362581","wikidata":"https://www.wikidata.org/wiki/Q10881532","display_name":"Molecular oncology","level":4,"score":0.2535000145435333},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.2529999911785126},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.2522999942302704}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D008495","descriptor_name":"Medical Oncology","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D010353","descriptor_name":"Patient Education as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D057285","descriptor_name":"Precision Medicine","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/01.jaa.0000000000000408","doi":"https://doi.org/10.1097/01.jaa.0000000000000408","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.jaa.0000000000000408","pdf_url":null,"source":{"id":"https://openalex.org/S4393917531","display_name":"JAAPA","issn_l":"0893-7400","issn":["0893-7400","1547-1896"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["doyens","medline","norway-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAAPA","raw_type":"journal-article"},{"id":"pmid:42647673","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42647673","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAAPA : official journal of the American Academy of Physician Assistants","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W2137228442","https://openalex.org/W2621271973","https://openalex.org/W2902218997","https://openalex.org/W2958196506","https://openalex.org/W2995808512","https://openalex.org/W3093085805","https://openalex.org/W3156985612","https://openalex.org/W3165576985","https://openalex.org/W4220709633","https://openalex.org/W4280490473","https://openalex.org/W4281640394","https://openalex.org/W4281749372","https://openalex.org/W4285992810","https://openalex.org/W4308766741","https://openalex.org/W4378801565","https://openalex.org/W4379521920","https://openalex.org/W4380987439","https://openalex.org/W4390575639","https://openalex.org/W4391659604","https://openalex.org/W4401093107","https://openalex.org/W4402472398","https://openalex.org/W4402548585","https://openalex.org/W4403912600","https://openalex.org/W4404259671","https://openalex.org/W4409698799","https://openalex.org/W4415677336","https://openalex.org/W7125981927"],"related_works":[],"abstract_inverted_index":{"ABSTRACT:":[0],"Recent":[1],"advances":[2],"in":[3,106,136],"breast":[4,33,158],"cancer":[5,34,159],"management":[6],"have":[7,59,67,97],"transformed":[8],"treatment":[9,69,90,128,155],"across":[10,157],"molecular":[11],"subtypes":[12],"and":[13,31,53,95,112,147,164],"expanded":[14,68],"the":[15,166],"role":[16,135],"of":[17],"precision":[18,138],"oncology.":[19],"Hormone":[20],"receptor-positive":[21],"(HR-positive),":[22],"human":[23],"epidermal":[24],"growth":[25],"factor":[26],"receptor":[27,57],"2-positive":[28],"(HER2-positive),":[29],"HER2-low,":[30],"triple-negative":[32],"(TNBC)":[35],"each":[36],"demonstrate":[37],"distinct":[38],"biologic":[39],"behavior":[40],"requiring":[41],"tailored":[42],"therapeutic":[43,99],"strategies.":[44],"In":[45,92],"HR-positive":[46],"disease,":[47],"cyclin-dependent":[48],"kinase":[49],"4/6":[50],"(CDK4/6)":[51],"inhibitors":[52],"next-generation":[54,110],"selective":[55],"estrogen":[56],"degraders":[58],"improved":[60],"survival,":[61],"while":[62],"HER2-directed":[63],"antibody-drug":[64],"conjugates":[65],"(ADCs)":[66],"options":[70,100],"beyond":[71],"traditional":[72],"HER2-positive":[73],"disease.":[74,104],"HER2-low":[75],"disease":[76],"has":[77],"recently":[78],"emerged":[79],"as":[80],"a":[81,87],"therapeutically":[82],"actionable":[83],"HER2-expression":[84],"category,":[85],"addressing":[86],"previously":[88],"limited":[89],"space.":[91],"TNBC,":[93],"immunotherapy":[94],"ADCs":[96],"broadened":[98],"for":[101],"historically":[102],"difficult-to-treat":[103],"Advances":[105],"genomic":[107,145],"profiling,":[108],"including":[109],"sequencing":[111],"circulating":[113],"tumor":[114],"DNA":[115],"testing,":[116],"allow":[117],"clinicians":[118],"to":[119,122],"identify":[120],"biomarkers":[121],"guide":[123],"targeted":[124],"therapy":[125],"selection.":[126],"As":[127],"complexity":[129],"increases,":[130],"APPs":[131],"play":[132],"an":[133],"essential":[134],"implementing":[137],"oncology":[139],"through":[140],"patient":[141],"education,":[142],"toxicity":[143],"management,":[144],"counseling,":[146],"clinical":[148],"trial":[149],"coordination.":[150],"This":[151],"review":[152],"summarizes":[153],"current":[154],"strategies":[156],"subtypes,":[160],"highlights":[161],"emerging":[162],"therapies,":[163],"emphasizes":[165],"expanding":[167],"APP":[168],"role.":[169]},"counts_by_year":[],"updated_date":"2026-09-23T05:00:35.095934","created_date":"2026-08-27T00:00:00"}